With several Phase III trials suggesting early intervention in smoldering multiple myeloma (SMM) is beneficial, this precursor stage of multiple myeloma represents a hot topic in the field right now. In this video, Sagar Lonial, MD, Winship Cancer Institute of Emory University, Atlanta, GA, talks on the different regimens being investigated for early SMM intervention. This interview took place during the 2021 European Myeloma Network (EMN) congress.

свернуть